As GLP-1 therapies reshape obesity care, one biotech company is betting that the root cause of Type 2 diabetes isn't only excessive weight but a specific fat-cell dysfunction. AdipoPharma LLC today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results